Natco Pharma shares surge 5% after US FDA's tentative nod Olaparib tablets

Natco Pharma shares climbed as much as 4.5% on Monday, touching an intraday high of Rs 987.55 on the NSE, after the company announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its generic version of Olaparib Tablets.The pharmaceutic...

First seen 21h ago · latest update 21h ago · India · business